--- title: "Mannatech says it regained Nasdaq stockholders' equity compliance" url: "https://aibio.space/news/mannatech-says-regained-nasdaq-stockholders-equity-compliance/" publisher: "aibio.space (Biotech Investor Relations News)" date: "2026-10-14" section: "Listings" tickers: "NASDAQ:MTEX" source: "https://www.sec.gov/Archives/edgar/data/1056358/000143774926032638/mtex20261012_8k.htm" summary: "Mannatech said a Swiss holding company transaction and a pro forma tax adjustment put it back above Nasdaq's stockholders' equity minimum, subject to revie" --- By the aibio.space news desk. Sources - [MANNATECH INC 8-K (2026-10-14)](https://www.sec.gov/Archives/edgar/data/1056358/000143774926032638/mtex20261012_8k.htm) - [MANNATECH INC financial data (SEC XBRL)](https://www.sec.gov/Archives/edgar/data/1056358/000143774926012430/) [MTEX](https://aibio.space/companies/mannatech/) 2026-10-14 # Mannatech says it regained Nasdaq stockholders' equity compliance Tickers [MTEX](https://aibio.space/companies/mannatech/) Mannatech said a Swiss holding company transaction and a pro forma tax adjustment put it back above Nasdaq's stockholders' equity minimum, subject to review and to Nasdaq's view. ## Key facts - **Company**: MANNATECH INC (NASDAQ: MTEX) - **News type**: Listings - **Primary source**: [MANNATECH INC 8-K (2026-10-14)](https://www.sec.gov/Archives/edgar/data/1056358/000143774926032638/mtex20261012_8k.htm) *The Capitol dome and spring blossom. Photo: Angie Drake, CC0, via Wordpress. The picture shows the field, not the companies named.* Mannatech, Incorporated (NASDAQ: [MTEX](https://aibio.space/companies/mannatech/)) said in a Form 8-K dated October 14, 2026 that it believes it has regained compliance with the Nasdaq minimum stockholders' equity requirement. The company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC on April 20, 2026, saying it was not in compliance with the $2,500,000 minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1). The company had disclosed that letter in a Form 8-K filed on or about April 24, 2026. ## The equity shortfall The stockholders' equity reported in the company's annual report on Form 10-K for the year ended December 31, 2025 was $(5,223,000) when the deficiency letter arrived. As of June 30, 2026, stockholders' equity reported in its quarterly report on Form 10-Q was $(4,970,000). ## The Swiss holding company transaction Subsequent to the quarter ended September 30, 2026, Mannatech entered into a share purchase agreement under which it acquires 100% direct ownership of Mannatech Swiss Holdings GmbH. The Swiss holding company was previously held indirectly through Mannatech (Gibraltar) Holdings Limited. The company said that, based on a ruling it received from the Swiss Federal Tax Administration, the transaction and the resulting direct ownership qualify distributions from the Swiss holding company for a reduced 5% withholding tax rate under Article 10(2)(a) of the income tax treaty between the United States and Switzerland. That rate replaces higher withholding rates previously applicable to certain of the company's foreign unremitted earnings. ## How the company reached its view Management's view that the company has regained compliance is based on the transaction and other matters described in the filing, the company said. The figures underlying the assessment are presented on a pro forma basis. They apply management's reassessment of the company's deferred tax liability related to unremitted foreign earnings, on a jurisdiction-by-jurisdiction basis, to the stockholders' equity reported in the June 30, 2026 Form 10-Q. The company said this pro forma adjustment will be reviewed by its independent registered public accounting firm in connection with the Form 10-Q for the quarter ending September 30, 2026. Mannatech expects to file that report on or before November 16, 2026. ## Nasdaq monitoring Nasdaq has told the company it will continue to monitor compliance with the stockholders' equity requirement. If the company's next annual report, the Form 10-K for the year ending December 31, 2026, does not show compliance, the company may be subject to delisting. Any such determination could be appealed to a Nasdaq Hearings Panel. ## Financial position The annual report figures in SEC XBRL data show revenue of $108.0 million for 2025, compared with $117.9 million for 2024. The company reported a net loss of $15.2 million for 2025, against net income of $2.5 million for 2024. Operations used $3.0 million of cash in 2025, after providing $2.3 million in 2024. Year-end cash and cash equivalents were $6.2 million at December 31, 2025, against $11.4 million at December 31, 2024. The quarterly report shows cash and cash equivalents of $6.0 million at June 30, 2026. ## The risks ahead The regained-compliance claim is management's own view. It rests on a pro forma adjustment that the company's auditor has not yet reviewed, and the filing says there can be no assurance that Nasdaq will agree, that the company will regain or maintain compliance, or that the stock will stay listed. Equity was still negative at $(4,970,000) as of June 30, 2026, and the company lost $15.2 million in 2025 while year-end cash fell. The auditor review comes with the Form 10-Q, which the company expects to file on or before November 16, 2026. Nasdaq will test compliance again with the 2026 Form 10-K, and a failure could lead to delisting. [Report an error](https://aibio.space/reputation/#correction) ## Companies in this story MTEX MANNATECH INC NASDAQ ยท United States Open the starter desk ## More in Listings Listings ### [Propanc Biopharma faces Nasdaq delisting on bid price, plans to appeal](https://aibio.space/news/propanc-biopharma-faces-nasdaq-delisting-bid-price-plans-appeal/) Oct 29, 2026 Listings ### [Reviva asks stockholders to approve reverse split of up to 1-for-100](https://aibio.space/news/reviva-asks-stockholders-approve-reverse-split-up-1-100/) Oct 29, 2026 Listings ### [Nasdaq to delist Glucotrack shares after bid price exception ends](https://aibio.space/news/nasdaq-delist-glucotrack-shares-after-bid-price-exception-ends/) Oct 28, 2026 --- Source page: https://aibio.space/news/mannatech-says-regained-nasdaq-stockholders-equity-compliance/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Mannatech says it regained Nasdaq stockholders' equity compliance", 2026-10-14, https://aibio.space/news/mannatech-says-regained-nasdaq-stockholders-equity-compliance/